37P Synthetic tumour-infiltrating interleukin (IL)-12 for targeted and tolerable immunotherapy reduces metastasis in pancreatic cancer. (December 2022) - Herpels, M.; Mansurov, A.; Ragulan, C.; Hussain, A.; Ishihara, J.; Sadanandam, A.